<?xml version="1.0" encoding="UTF-8"?>
<p id="para270">49 patients (65%; 95% CI 54–76) had an objective response after MATRix–RICE induction: response was complete in 29 (39%; 28–50) patients and partial in 20 (27% [95% CI 17–37]; eight [40%] patients had residual disease in the CNS, six [30%] had residual disease in extra-CNS organs, and six [30%] patients had residual disease in both).</p>
